Hepatitis C Vaccine being developed by GlaxoSmithKline

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at 1-888-411-7578.

Wonderful cures for hepatitis C are on the horizon, but no disease has been eradicated from the world by a cure alone; to really stamp out a disease, we also need widespread use of a preventive vaccine, such as for polio or smallpox. A vaccine for hepatitis C is being developed by GlaxoSmithKline and researchers at Oxford University, based on the same technology being used to develop an Ebola vaccine. For more information, see 

“GSK hepatitis C shot shows promise, bodes well for Ebola vaccines” (Reuters, Nov. 5, 2014): http://www.trust.org/item/20141105185933-59ri5

At the Nov. 6-7, 2014 First International Hepatitis Cure & Eradication Meeting in Toronto, researchers also reported on why a vaccine is needed, and how it might be developed. See slideshow here: http://regist2.virology-education.com/2014/1stHepCure/11_Cox.pdf

 

 

Leave a Reply